Does systemic inflammation promote autoimmune thyroid activity and impair thyroid hormone signaling?

Systemic inflammation acts as a significant disruptor of the thyroid axis, influencing both the production of autoimmune antibodies and the cellular utilization of thyroid hormones. Research indicates that inflammatory states create a cascade that alters how the body processes and responds to thyroxine (T4) and triiodothyronine (T3).

Clinical and Mechanistic Evidence for Autoimmunity

The link between systemic inflammation and thyroid autoimmunity is well-supported by clinical data correlating inflammatory markers with antibody titers.

• Correlation with Biomarkers: In patients with autoimmune thyroiditis, high-sensitivity C-reactive protein (hs-CRP) shows a strong positive correlation (r = 0.58) with thyroperoxidase antibodies (TPOAb).
• Immune Cell Polarization: Inflammation drives a Th1/Th17 immune shift. Pro-inflammatory cytokines, specifically IL-17 and IFN-γ, facilitate the infiltration of lymphocytes into thyroid tissue.
• Cellular Destruction: Activation of the NLRP3 inflammasome leads to the release of IL-1β and IL-18, which triggers thyrocyte pyroptosis (inflammatory cell death) and further stimulates the production of TPOAb and thyroglobulin antibodies (TgAb).

Alteration of Deiodinase Activity

Systemic inflammation directly impairs the peripheral conversion of thyroid hormones by modulating deiodinase enzymes, a process often seen in Non-Thyroidal Illness Syndrome (NTIS).

• Enzyme Suppression: Inflammatory cytokines like IL-6 and TNF-alpha activate the NF-κB pathway, which suppresses the mRNA expression and activity of Type 1 (DIO1) and Type 2 (DIO2) deiodinases. These enzymes are essential for converting T4 into the active T3.
• Hormone Inactivation: Concurrently, inflammation upregulates Type 3 deiodinase (DIO3), which actively converts T4 into inactive reverse T3 (rT3). This dual action—decreasing activation while increasing inactivation—significantly reduces cellular T3 availability and nuclear receptor signaling.

Disruption of Thyroid Hormone Transport

Even when circulating hormone levels appear stable, inflammation can impair the transport of these hormones into target tissues, particularly the brain.

• Transporter Downregulation: Evidence from inflammatory models (such as LPS-induced endotoxemia) shows a significant downregulation of critical transporters, including Monocarboxylate Transporter 8 (MCT8) and Organic Anion Transporting Polypeptide 1C1 (OATP1C1).
• Tissue deprivation: Reduced transporter expression at the blood-brain barrier and other tissues prevents T3 and T4 from entering cells. This creates a state of "tissue-specific hypothyroidism," where cells are deprived of thyroid signaling despite normal serum hormone concentrations.

Bottom line

Systemic inflammation impairs thyroid health through a three-pronged mechanism: it accelerates autoimmune destruction via T-cell shifts, reduces the production of active T3 by altering deiodinase enzymes, and blocks cellular hormone uptake by downregulating key transporters like MCT8. This results in impaired thyroid signaling and metabolic dysregulation even if standard thyroid blood tests remain within normal limits.